| Literature DB >> 27468151 |
David J Wood1, David Buttar2, John G Cumming2, Andrew M Davis3, Ulf Norinder4, Sarah L Rodgers5.
Abstract
We present an automated QSAR procedure that is used in AstraZeneca's AutoQSAR system. The approach involves automatically selecting the most predictive models from pools of both global and local models. The effectiveness of this QSAR modelling strategy is demonstrated with a retrospective study that uses a diverse selection of 9 early stage AstraZeneca drug discovery projects and 3 physicochemical endpoints: LogD; solubility and human plasma protein binding. We show that the strategy makes a statistically significant improvement to the accuracy of predictions when compared to an updating global strategy, and that the systematic biases inherent in the global model predictions are almost completely removed. This improvement is attributed to the model selection aspect of the strategy.Entities:
Keywords: Automated QSAR; Model Selection; QSAR; QSPR
Year: 2011 PMID: 27468151 DOI: 10.1002/minf.201100107
Source DB: PubMed Journal: Mol Inform ISSN: 1868-1743 Impact factor: 3.353